1)Hashimoto M, Ishikawa M, Mori E, et al. Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study. Cerebrospinal Fluid Res. 2010; 7: 18
|
|
|
2)Kawaguchi T, Hirata Y, Bundo M, et al. Role of computerized tomographic cisternography in idiopathic normal pressure hydrocephalus. Acta Neurochir (Wien). 2011; 153: 2041-8
|
|
|
3)Ishii K, Hashimoto M, Hayashida K, et al. A multi-center brain perfusion SPECT study evaluating idiopathic normal-pressure hydrocephalus on neurological improvement. Dement Geriatr Cogn Disord. 2011; 32: 1-10
|
|
|
4)Sakakibara R, Uchida Y, Ishii K, et al. Correlation of right frontal hypoperfusion and urinary dysfunction in iNPH: a SPECT study. Neurourol Urodyn. 2012; 31: 50-5
|
|
|
5)Ishikawa M, Hashimoto M, Mori E, et al. The value of the cerebrospinal fluid tap test for predicting shunt effectiveness in idiopathic normal pressure hydrocephalus. Fluids Barriers CNS. 2012; 9: 1
|
|
|
6)Miyake H, Kajimoto Y, Murai H, et al. Assessment of a quick reference table algorithm for determining initial postoperative pressure settings of programmable pressure valves in patients with idiopathic normal pressure hydrocephalus: SINPHONI subanalysis. Neurosurgery. 2012; 71: 722-8
|
|
|
7)Kazui H, Mori E, Hashimoto M, et al. Effect of shunt operation on idiopathic normal pressure hydrocephalus patients in reducing caregiver burden: evidence from SINPHONI. Dement Geriatr Cogn Disord. 2011; 31: 363-70
|
|
|
8)Hellström P, Klinge P, Tans J, et al. A new scale for assessment of severity and outcome in iNPH. Acta Neurol Scand. 2012; 126: 229-37
|
|
|
9)Klinge P, Hellström P, Tans J, et al. One-year outcome in the European multicentre study on iNPH. Acta Neurol Scand. 2012; 126: 145-53
|
|
|
10)Hellström P, Klinge P, Tans J, et al. The neuropsychology of iNPH: findings and evaluation of tests in the European multicentre study. Clin Neurol Neurosurg. 2012; 114; 130-4
|
|
|
11)Wikkelsø C, Hellström P, Klinge PM, et al. The European iNPH Multicentre Study on the predictive values of resistance to CSF outflow and the CSF Tap Test in patients with idiopathic normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry. 2013; 84: 562-8
|
|
|
12)Leinonen V, Koivisto AM, Alafuzoff I, et al. Cortical brain biopsy in long-term prognostication of 468 patients with possible normal pressure hydrocephalus. Neurodegener Dis. 2012; 10; 166-9
|
|
|
13)Jeppsson A, Zetterberg H, Blennow K, et al. Idiopathic normal-pressure hydrocephalus Pathophysiology and diagnosis by CSF biomarkers. Neurology. 2013; 80: 1385-92
|
|
|
14)Miyajima M, Nakajima M, Ogino I, et al. Soluble amyloid precursor protein α in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus. Eur J Neurol. 2013; 20: 236-42
|
|
|
15)Hattori T, Ito K, Aoki S, et al. White matter alteration in idiopathic normal pressure hydrocephalus: tract-based spatial statistics study. AJNR Am J Neuroradiol. 2012; 33: 97-103
|
|
|
16)Koyama T, Marumoto K, Domen K, et al. Diffusion tensor imaging of idiopathic normal pressure hydrocephalus: a voxel-based fractional anisotropy study. Neurol Med Chir (Tokyo). 2012; 52: 68-74
|
|
|
17)Chistyakov AV, Hafner H, Sinai A, et al. Motor cortex disinhibition in normal-pressure hydrocephalus. J Neurosurg. 2012; 116: 453-9
|
|
|
18)Greitz D. Radilogical assessment of hydrocephalus: new theories and implications for therapy. Neurosurg Rev. 2004; 27: 145-65
|
|
|
19)Klarica M, Mise B, Vladic A, et al. “Compensated Hyperosmolarity” of cerebrospinal fluid and the development of hydrocephalus. Neuroscience. 2013; 248C: 278-89
|
|
|
20)Krishnamurthy S, Li J, Schultz L, et al. Intraventricular infusion of hyperosmolar dextran induces hydrocephalus: a novel animal model of hydrocephalus. Cerebrospinal Fluid Res. 2009; 6: 16
|
|
|